Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

iBio, Inc. (IBIO)

Pharmaceutical Preparations

https://www.ibioinc.com

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.

600 MADISON AVENUE, SUITE 1601
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/19/2008

Market Cap

15,393,287

Shares Outstanding

1,410,000

Weighted SO

2,005,036

Total Employees

N/A

Upcoming Earnings

09/25/2024

Similar Tickers

JAGX --.--%

ONTX --.--%

GOVX --.--%

OCGN --.--%

TNXP --.--%

ACST --.--%

DFFN --.--%

SONN --.--%

PALI --.--%

Beta

-3.3610

Last Div

0.0000

Range

1.02-8.8

Chg

-0.0650

Avg Vol

127264

Mkt Cap

15393287

Exch

AMEX

Country

US

Phone

979 446 0027

DCF Diff

4.3931

DCF

-1.0431

Div Yield

0.0000

P/S

307.8657

EV Multiple

-1.5810

P/FV

0.2666

Div Yield %

0.0000

P/E

-0.2861

PEG

-0.0029

Payout

0.0000

Current Ratio

1.6867

Quick Ratio

1.6867

Cash Ratio

0.2901

DSO

102959.2000

DIO

0.0000

Op Cycle

102959.2000

DPO

448.2200

CCC

102510.9800

Gross Margin

-19.0000

Op Margin

-363.8000

Pretax Margin

-342.5800

Net Margin

-463.2400

Eff Tax Rate

-0.1430

ROA

-0.4618

ROE

-1.4788

ROCE

-0.6332

NI/EBT

1.3522

EBT/EBIT

0.9417

EBIT/Rev

-363.8000

Debt Ratio

0.3456

D/E

0.6972

LT Debt/Cap

0.1312

Total Debt/Cap

0.4108

Int Coverage

-141.0078

CF/Debt

-1.0771

Equity Multi

2.0172

Rec Turnover

0.0035

Pay Turnover

0.8143

Inv Turnover

0.0000

FA Turnover

0.0076

Asset Turnover

0.0010

OCF/Share

-5.0283

FCF/Share

-5.1646

Cash/Share

1.6741

OCF/Sales

-373.4000

FCF/OCF

1.0271

CF Coverage

-1.0771

ST Coverage

-1.3749

CapEx Coverage

-36.8972

Div&CapEx Cov

-36.8972

P/BV

0.2666

P/B

0.2666

P/S

307.8657

P/E

-0.2861

P/FCF

-0.8027

P/OCF

-0.3550

P/CF

-0.3550

PEG

-0.0029

P/S

307.8657

EV Multiple

-1.5810

P/FV

0.2666

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 26, 07:15 iBio Amends and Extends Maturity of Credit Agreement GlobeNewswire Inc. Nov 27, 17:20 iBio Announces Reverse Stock Split GlobeNewswire Inc. Nov 01, 08:24 iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 Bispecific

Revenue Product Segmentation